{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:38:29Z","timestamp":1780875509026,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11060-020-03663-w","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:35:00Z","timestamp":1610476500000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome"],"prefix":"10.1007","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-3499","authenticated-orcid":false,"given":"Rodney E.","family":"Wegner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam U.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"3663_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1042-3680(18)30365-6","volume":"7","author":"JD Johnson","year":"1996","unstructured":"Johnson JD, Young B (1996) Demographics of brain metastasis. Neurosurg Clin N Am 7:337\u2013344","journal-title":"Neurosurg Clin N Am"},{"key":"3663_CR2","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1200\/JCO.19.01414","volume":"37","author":"AM Hong","year":"2019","unstructured":"Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T, Shivalingam B, Long GV, Menzies AM, Hruby G, Drummond KJ, Mandel C, Middleton MR, Reisse CH, Paton EJ, Steel V, Williams NC, Scolyer RA, Morton RL, Thompson JF (2019) Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial. J Clin Oncol 37:3132\u20133141. https:\/\/doi.org\/10.1200\/JCO.19.01414","journal-title":"J Clin Oncol"},{"key":"3663_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29:134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655","journal-title":"J Clin Oncol"},{"key":"3663_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/nop\/npz004","volume":"6","author":"CM Lanier","year":"2019","unstructured":"Lanier CM, Hughes R, Ahmed T, LeCompte M, Masters AH, Petty WJ, Ruiz J, Triozzi P, Su J, O\u2019Neill S, Watabe K, Cramer CK, Laxton AW, Tatter SB, Wang G, Whitlow C, Chan MD (2019) Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neurooncol Pract 6:402\u2013409. https:\/\/doi.org\/10.1093\/nop\/npz004","journal-title":"Neurooncol Pract"},{"key":"3663_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0360-3016(82)90060-8","volume":"8","author":"LL Doss","year":"1982","unstructured":"Doss LL, Memula N (1982) The radioresponsiveness of melanoma. Int J Radiat Oncol Biol Phys 8:1131\u20131134","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3663_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2016.12.003","volume":"110","author":"S Espenel","year":"2017","unstructured":"Espenel S, Vallard A, Rancoule C, Garcia MA, Guy JB, Chargari C, Deutsch E, Magne N (2017) Melanoma: last call for radiotherapy. Crit Rev Oncol Hematol 110:13\u201319. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.12.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"3663_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/0360-3016(85)90223-8","volume":"11","author":"B Fertil","year":"1985","unstructured":"Fertil B, Malaise EP (1985) Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11:1699\u20131707","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3663_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316:401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"3663_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2018.06.017","volume":"128","author":"P Gabani","year":"2018","unstructured":"Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD (2018) Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes. Radiother Oncol 128:266\u2013273. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.017","journal-title":"Radiother Oncol"},{"key":"3663_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40425-019-0588-y","volume":"7","author":"G Minniti","year":"2019","unstructured":"Minniti G, Anzellini D, Reverberi C, Cappellini GCA, Marchetti L, Bianciardi F, Bozzao A, Osti M, Gentile PC, Esposito V (2019) Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity. J Immunother Cancer 7:102. https:\/\/doi.org\/10.1186\/s40425-019-0588-y","journal-title":"J Immunother Cancer"},{"key":"3663_CR11","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1172\/JCI69219","volume":"123","author":"A Kalbasi","year":"2013","unstructured":"Kalbasi A, June CH, Haas N, Vapiwala N (2013) Radiation and immunotherapy: a synergistic combination. J Clin Investig 123:2756\u20132763. https:\/\/doi.org\/10.1172\/JCI69219","journal-title":"J Clin Investig"},{"key":"3663_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/2326-6066.CIR-14-0069","volume":"2","author":"C Tang","year":"2014","unstructured":"Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, Massarelli E, Hong D, Naing A, Diab A, Gomez D, Ye H, Heymach J, Komaki R, Allison JP, Sharma P, Welsh JW (2014) Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res 2:831\u2013838. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0069","journal-title":"Cancer Immunol Res"},{"key":"3663_CR13","doi-asserted-by":"publisher","first-page":"15618","DOI":"10.1038\/ncomms15618","volume":"8","author":"C Vanpouille-Box","year":"2017","unstructured":"Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S (2017) DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun 8:15618. https:\/\/doi.org\/10.1038\/ncomms15618","journal-title":"Nat Commun"},{"key":"3663_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03485-w","author":"RJ White","year":"2020","unstructured":"White RJ, Abel S, Horne ZD, Lee J, Edington H, Greenberg L, Younes H, Hilton C, Wegner RE (2020) Melanoma brain metastases: is it time to eliminate radiotherapy? J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-020-03485-w","journal-title":"J Neurooncol"},{"key":"3663_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-018-2795-7","volume":"138","author":"R Rahman","year":"2018","unstructured":"Rahman R, Cortes A, Niemierko A, Oh KS, Flaherty KT, Lawrence DP, Sullivan RJ, Shih HA (2018) The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity. J Neurooncol 138:299\u2013306. https:\/\/doi.org\/10.1007\/s11060-018-2795-7","journal-title":"J Neurooncol"},{"key":"3663_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3171\/2016.9.JNS161585","volume":"127","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar O, Shih HH, Xu Z, Schlesinger D, Sheehan JP (2017) The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. J Neurosurg 127:1007\u20131014. https:\/\/doi.org\/10.3171\/2016.9.JNS161585","journal-title":"J Neurosurg"},{"key":"3663_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.29245\/2578-3009\/2019\/2.1171","volume":"3","author":"REAS Wegner","year":"2019","unstructured":"Wegner REAS, White RJ, Finely G, Monga D, Colonias A, Verma V (2019) Time from stereotactic radiotherapy to immunotherapy is a predictor for outcome in stage IV non-small cell lung cancer. J Immunol Sci 3:7","journal-title":"J Immunol Sci"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03663-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T08:26:23Z","timestamp":1614327983000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03663-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3663"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03663-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}